Pathway analysis to identify genetic variants associated with efficacy of adalimumab in rheumatoid arthritis
{{output}}
Aim: About 30% of rheumatoid arthritis patients have no clinical benefit from TNF inhibitors. Genome-wide association (GWA) and candidate gene studies tested several putative genetic variants for TNF inhibitor efficacy with incon... ...
